dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Salgia, Ravi |
dc.contributor.author | Sattler, Martin |
dc.contributor.author | Scheele, Juergen |
dc.contributor.author | Stroh, Christopher |
dc.contributor.author | Felip Font, Enriqueta |
dc.date.accessioned | 2021-10-22T09:11:15Z |
dc.date.available | 2021-10-22T09:11:15Z |
dc.date.issued | 2020-07-01 |
dc.identifier.citation | Salgia R, Sattler M, Scheele J, Stroh C, Felip E. The promise of selective MET inhibitors in non-small cell lung cancer with MET exon 14 skipping. Cancer Treat Rev. 2020 Jul 1;87:102022. |
dc.identifier.issn | 0305-7372 |
dc.identifier.uri | https://hdl.handle.net/11351/6448 |
dc.description | Inhibidor de MET; NSCLC |
dc.description.sponsorship | This work was supported by Merck KGaA, Darmstadt, Germany . No grant number is applicable. |
dc.language.iso | eng |
dc.publisher | Elsevier |
dc.relation.ispartofseries | Cancer Treatment Reviews;87 |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Pulmons - Càncer - Tractament |
dc.subject | Proteïnes quinases - Inhibidors - Ús terapèutic |
dc.subject.mesh | Carcinoma, Non-Small-Cell Lung |
dc.subject.mesh | Protein Kinase Inhibitors |
dc.subject.mesh | /therapeutic use |
dc.title | The promise of selective MET inhibitors in non-small cell lung cancer with MET exon 14 skipping |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1016/j.ctrv.2020.102022 |
dc.subject.decs | carcinoma de pulmón de células no pequeñas |
dc.subject.decs | inhibidores de proteínas cinasas |
dc.subject.decs | /uso terapéutico |
dc.relation.publishversion | https://doi.org/10.1016/j.ctrv.2020.102022 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Salgia R] Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA, USA. [Sattler M] Department of Medical Oncology, Dana–Farber Cancer Institute, Boston, MA, USA. Department of Medicine, Harvard Medical School, Boston, MA, USA d Merck KGaA, Darmstadt, Germany. [Scheele J, Stroh C] Merck KGaA, Darmstadt, Germany. [Felip E] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain |
dc.identifier.pmid | 32334240 |
dc.identifier.wos | 000540249800001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |